Serious cardiovascular events peak in the morning hours, highlighting the importance of understanding circadian triggers for rational pharmaceutical development.
No takes yet. Share an insight, caveat, or question.
Highlights potential for morning-focused prevention; leaves open prospective chronotherapy trials before practice change.
J MULLER (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: